| Structure |
Chemical Name |
CAS |
MF |
 |
3-bromo-5-(methyl-d3)pyridin-2-amine |
2256740-05-1 |
C6H4BrD3N2 |
 |
Phenylethyl Alcohol Agar Base |
|
|
 |
1-(4-bromo-6-cyclopropylpyridin-2-yl)ethan-1-one |
2645416-19-7 |
C10H10BrNO |
 |
suppressors of cytokine signaling 3 |
|
|
 |
4-iodo-2-(methoxy-d3)-5-(trifluoromethyl)pyridine-3,6-d2 |
2891521-31-4 |
C7D5F3INO |
 |
5-(1,3-dioxan-5-yl)-2-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)pyridine |
2241866-35-1 |
C15H22BNO4 |
 |
4-(3-methoxyphenyl)-4H-1,2,4-triazol-3-amine |
2460500-95-0 |
C9H10N4O |
 |
4-methoxy-2-methyl-5-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)thiazole |
2819706-00-6 |
C11H18BNO3S |
 |
Human Attacin,Att ELISA Kit |
|
|
 |
5-bromo-2-chloro-4-fluoro-3-(methyl-d3)pyridine |
|
|
 |
2-bromo-6-(1,1-difluoroethyl-2,2,2-d3)pyridine-3,4,5-d3 |
2891511-42-3 |
C7BrD6F2N |
 |
Human Ubiquitin,Ub ELISA Kit |
|
|
 |
DMEM low glucose medium (containing 25 MM HEPES) |
|
|
 |
4-(Ethoxycarbonyl)pyridine-2-boronic acid pinacol ester |
1241898-91-8 |
C14H20BNO4 |
 |
Alkaline L-J Medium Base |
|
|
 |
5-Bromo-4-chloro-2-(diethylamino-d10)-pyrimidine |
1643542-93-1 |
C8H11BrClN3 |
 |
4-Chloro-2-cyclopropyl-6-(1H-pyrazol-1-yl)pyrimidine |
1412959-54-6 |
C10H9ClN4 |
 |
Sevelamer carbonate |
845273-93-0 |
C7H14ClNO4 |
 |
RPMI 1640 medium (sugar-free, containing double antibodies) |
|
|
 |
Human Desmopressin/1-desamino-8-D-arginine vasopressin,dDAVP ELISA Kit |
|
|
 |
2-Chloro-3-(cyclobutoxy)pyridine |
1417518-38-7 |
C9H10ClNO |
 |
Rabbit cholest erolester transfer protein,CETP ELISA Kit |
|
|
 |
2-Hydroxy-4-(3-furyl)-6-methylpyrimidine |
1412956-91-2 |
C9H8N2O2 |
 |
Salt Czapek Dox Agar Medium |
|
|
 |
Cyclic AMP Select EIA Kit |
|
|
 |
Adenosine, 8-bromo-, cyclic 2',3'-(hydrogen phosphate) |
42391-15-1 |
C10H11BrN5O6P |
 |
ボソリチド(遺伝子組換え) |
1480724-61-5 |
|
 |
2-Fluoro-D-homophenylalanine |
1260606-28-7 |
C10H12FNO2 |
 |
2-(3-(methyl-d3)piperidin-1-yl-2,2,3,4,4,5,5,6,6-d9)-5-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)pyrimidine-4,6-d2 |
2368224-92-2 |
C16H12BD14N3O2 |
 |
Matrigel Basement Membrane Matrix, Phenol Red-Free |
|
|
 |
4-Fluoro-2-methoxy-5-(trifluoromethyl)pyridine |
1227574-02-8 |
C7H5F4NO |
 |
5-(methyl-d3)-2-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)pyridine |
2241869-89-4 |
C12H18BNO2 |
 |
2-Amino-5-(n-propyl)pyridine-4-boronic acid pinacol ester |
2223050-17-5 |
C14H23BN2O2 |
 |
5-Bromo-6-(2-methylpiperidin-1-yl)pyridine-3-boronic acid pinacol ester |
1419478-33-3 |
C17H26BBrN2O2 |
 |
2-hydroxy-4-(2-furyl)-6-(tert-butyl)pyrimidine |
1412958-11-2 |
C12H14N2O2 |
 |
2-CHLORO-4-AMINO-3-(CYCLOPROPYL)PYRIDINE |
1381935-49-4 |
C8H9ClN2 |
 |
2-(1H-pyrazol-1-yl-d3)-4-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)pyridine-3,5,6-d3 |
2256710-07-1 |
C14H18BN3O2 |
 |
2-Chloro-4-(4-trifluoromethylphenyl)-6-methoxy-1,3,5-triazine |
1303967-80-7 |
C11H7ClF3N3O |
 |
6-Chloro-5-(3-hydroxypiperidin-1-yl)pyridine-3-boronic acid pinacol ester |
2222997-29-5 |
C16H24BClN2O3 |
 |
ANTI-ACAT-1 |
|
|
 |
2-Amino-4-(3-methylpiperidin-1-yl)-6-methylpyrimidine |
1412960-80-5 |
C11H18N4 |
 |
tert-アミルメタクリレート |
7383-24-6 |
C9H16O2 |
 |
4-Bromo-3-amino-6-(imidazol-1-yl)pyridine |
1381933-57-8 |
C8H7BrN4 |
 |
2-AMINO-6-(1H-PYRAZOL-1-YL)PYRIDINE |
1314355-21-9 |
C8H8N4 |
 |
4-AMINO-3,5-DIBROMO-2-(N-PROPYL)PYRIDINE |
1563532-48-8 |
C8H10Br2N2 |
 |
2-(2-ブロモフェニル)-4,6-ジフェニル-1,3,5-トリアジン |
77989-15-2 |
C21H14BrN3 |
 |
2-(pyridin-2-yl)-5-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)pyrimidine |
2223049-45-2 |
C15H18BN3O2 |
 |
1H-ベンズイミダゾール-5-オール HYDROBROMIDE |
41292-65-3 |
C7H6N2O |
 |
4-Hydroxy-2-methyl-6-(5-thiazolyl)pyrimidine |
1159819-06-3 |
C8H7N3OS |
![フマル酸ビス[(1R,3R,4S)-p-メンタン-3-イル]](/CAS/GIF/34675-24-6.gif) |
フマル酸ビス[(1R,3R,4S)-p-メンタン-3-イル] |
34675-24-6 |
C24H40O4 |
 |
Recombinant Cluster Of Differentiation 8b (CD8b) |
|
|
 |
5-(4-methoxyphenyl)-3-Pyridinol |
1258609-27-6 |
C12H11NO2 |
 |
2,4-Dibromo-6-cyclohexylpyridine |
1353854-94-0 |
C11H13Br2N |
 |
4-Bromo-1-(3-methoxyphenyl)pyrazole |
1353856-04-8 |
C10H9BrN2O |
 |
2-Bromo-5-(4-hydroxypiperidino)pyridine |
1314353-88-2 |
C10H13BrN2O |
 |
4-Amino-2-(ethylmethylamino)pyridine |
1248692-37-6 |
C8H13N3 |
 |
2-Bromo-4-amino-5-(3-methoxyphenyl)pyridine |
1381938-75-5 |
C12H11BrN2O |
 |
(25RS)-ルスコゲニン |
874485-32-2 |
C27H42O4 |
 |
Chromosome 17 open reading frame 75 antibody |
|
|
 |
(6-(2-(methyl-d3)propan-2-yl-1,1,1,3,3,3-d6)pyridin-3-yl)boronic acid |
2241875-62-5 |
C9H14BNO2 |
 |
2-Chloro-5-(3,5-difluorophenyl)thiazole |
1215074-04-6 |
C9H4ClF2NS |
 |
2-(4-bromo-1H-imidazol-1-yl-2,5-d2)pyrimidin-4-amine |
2256743-78-7 |
C7H4BrD2N5 |
 |
Rat prothrombin fragment 1+2,F1+2 ELISA Kit |
|
|
 |
(S)-3-Amino-2-(4-chloro-phenyl)-propionic acid |
1001227-79-7 |
C9H10ClNO2 |
 |
CHO-K104.02 |
|
|
 |
4-Chloro-2-methyl-6-(2-fluorophenyl)pyrimidine |
1159816-02-0 |
C11H8ClFN2 |
 |
3,4-Dibromo-6-(5-pyrimidyl)pyridine |
1381942-27-3 |
C9H5Br2N3 |
 |
2-(4-bromo-1H-imidazol-1-yl-2,5-d2)-6-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)pyridine-3,4,5-d3 |
2256706-92-8 |
C14H17BBrN3O2 |
 |
Cell proliferation and toxicity detection kit |
|
|
 |
Recombinant Tar DNA Binding Protein 43kDa (TDP43) |
|
|
 |
4-Chloro-7-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)-1-(2,2,2-trifluoroethyl)-1H-indazol-3-amine |
2189684-53-3 |
C15H18BClF3N3O2 |
 |
4-Amino-2-(N-Boc-piperidin-3-yl)pyridine |
1563534-87-1 |
C15H23N3O2 |
 |
2-Amino-5-bromo-4-(1H-pyrazol-1-yl)pyridine |
1381942-41-1 |
C8H7BrN4 |
 |
3,4-Dibromo-6-(piperazin-1-yl)pyridine |
1381943-98-1 |
C9H11Br2N3 |
 |
4-Bromo-2-(2-methyl-4-fluorophenyl)pyrimidine |
1215073-46-3 |
C11H8BrFN2 |
 |
2-Amino-4-(pyridin-3-yl)-6-(iso-propyl)pyrimidine |
1412953-61-7 |
C12H14N4 |
 |
2-(5-methylpyridin-2-yl)-6-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)pyrazine |
2223027-63-0 |
C16H20BN3O2 |
 |
2-Hydroxy-5-(3-pyridyl)thiazole |
1215072-26-6 |
C8H6N2OS |
 |
4-bromo-2-iodopyridine-3,5,6-d3 |
2241865-02-9 |
C5BrD3IN |
 |
4-(1H-imidazol-1-yl-d3)pyrimidin-5,6-d2-2-amine |
2256747-11-0 |
C7H2D5N5 |
 |
4-(4-(trifluoromethyl)phenyl)-4H-1,2,4-triazol-3-amine |
2460491-64-7 |
C9H7F3N4 |
 |
5-bromo-1-methyl-4-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)-1H-1,2,3-triazole |
2364587-04-0 |
|
 |
ブタンジアール |
638-37-9 |
C4H6O2 |
 |
5-bromo-4-fluoro-2-(methyl-d3)pyridine-3,6-d2 |
2294944-83-3 |
C6H5BrFN |
![(2E,7E)-N'2,N'7-dicyano-1,3,6,8-tetraoxo-1,3,6,8-tetrahydrobenzo[lmn][3,8]phenanthroline-2,7-bis(carboximidamide)](/) |
(2E,7E)-N'2,N'7-dicyano-1,3,6,8-tetraoxo-1,3,6,8-tetrahydrobenzo[lmn][3,8]phenanthroline-2,7-bis(carboximidamide) |
|
|
 |
2-Bromo-6-(2-amino-5-pyrimidyl)pyrazine |
1159814-96-6 |
C8H6BrN5 |
 |
3-(2-hydroxypyridin-4-yl)tetrahydro-4H-pyran-4-one |
2806729-72-4 |
C10H11NO3 |
 |
2,3-Dibromo-4-(pyrrolidino)pyridine |
1381937-57-0 |
C9H10Br2N2 |
 |
5-bromo-2,4,6-tris(methyl-d3)pyrimidine |
2697155-74-9 |
C7BrD9N2 |
 |
Pyridine, 4-bromo-2-(2-oxazolyl)- |
1243363-48-5 |
C8H5BrN2O |
 |
3-bromo-6-ethyl-2-(trifluoromethyl)pyridine |
1211517-92-8 |
C8H7BrF3N |
 |
BENZENEMETHANAMINE, 3-AMINO-ALPHA,ALPHA-DIMETHYL- |
130631-19-5 |
C9H14N2 |
 |
2-hydroxy-4-(1H-4-methylpyrozol-1-yl)-6-(tert-butyl)pyrimidine |
1412957-17-5 |
C12H16N4O |
 |
2,3-bis(methyl-d3)-5-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)pyridine-4,6-d2 |
2241870-57-3 |
C13H12BD8NO2 |
 |
4-Bromo-2-(3-hydroxypyrrolidin-1-yl)pyridine |
1159819-21-2 |
C9H11BrN2O |
 |
2-Chloro-5-(2-methylimidazol-1-yl)pyrimidine |
1363254-17-4 |
C8H7ClN4 |
 |
2-(3-(methyl-d3)-1H-pyrazol-1-yl-4,5-d2)-5-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)pyrimidine-4,6-d2 |
2256705-32-3 |
C14H19BN4O2 |
 |
5-Bromo-2-amino-4-(iso-propyl)pyridine |
1381937-92-3 |
C8H11BrN2 |
 |
5-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)pyrimidine-2,4-d2 |
2241865-97-2 |
C10H15BN2O2 |
 |
3-(3-(methyl-d3)-1H-pyrazol-1-yl-4,5-d2)-5-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)pyridine-2,4,6-d3 |
2256705-33-4 |
C15H12BD8N3O2 |